Yong‐Bok Lee

5.0k total citations
239 papers, 4.0k citations indexed

About

Yong‐Bok Lee is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Yong‐Bok Lee has authored 239 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 38 papers in Pharmacology and 38 papers in Oncology. Recurrent topics in Yong‐Bok Lee's work include Drug Transport and Resistance Mechanisms (32 papers), Pharmacogenetics and Drug Metabolism (23 papers) and Analytical Methods in Pharmaceuticals (21 papers). Yong‐Bok Lee is often cited by papers focused on Drug Transport and Resistance Mechanisms (32 papers), Pharmacogenetics and Drug Metabolism (23 papers) and Analytical Methods in Pharmaceuticals (21 papers). Yong‐Bok Lee collaborates with scholars based in South Korea, United States and India. Yong‐Bok Lee's co-authors include Hea‐Young Cho, Seung‐Hyun Jeong, Ji-Hun Jang, Dae‐Duk Kim, Pil Joo Kim, Hoo‐Kyun Choi, Chul Soon Yong, In-Joon Oh, Prabagar Balakrishnan and Sook‐Jin Kim and has published in prestigious journals such as Journal of the American Chemical Society, Biomaterials and Bioresource Technology.

In The Last Decade

Yong‐Bok Lee

231 papers receiving 3.9k citations

Peers

Yong‐Bok Lee

BIOMA

Biswajit Mukherjee India

Mohammad Javed Ansari Saudi Arabia

Ho‐Chul Shin South Korea

Nakissa Sadrieh United States

Muhammad Sajid Hamid Akash Pakistan

Li Gan China

Pinaki Sengupta India

Kanwal Rehman Pakistan

Anil Kumar Dwivedi India

Éva Fenyvesi Hungary

Biswajit Mukherjee India

Yong‐Bok Lee

970 ×1.1

904 ×1.2

664 ×1.1

BIOMA

227 ×0.4

350 ×0.9

Citations per year, relative to Yong‐Bok Lee Yong‐Bok Lee (= 1×) peers Biswajit Mukherjee

Countries citing papers authored by Yong‐Bok Lee

Since Specialization

Citations

This map shows the geographic impact of Yong‐Bok Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Bok Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Bok Lee more than expected).

Fields of papers citing papers by Yong‐Bok Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Bok Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Bok Lee. The network helps show where Yong‐Bok Lee may publish in the future.

Co-authorship network of co-authors of Yong‐Bok Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Bok Lee. A scholar is included among the top collaborators of Yong‐Bok Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Bok Lee. Yong‐Bok Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeong, Seung‐Hyun, Ji-Hun Jang, & Yong‐Bok Lee. (2023). Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic–Pharmacodynamic Modeling. Biomedicines. 11(11). 3021–3021. 4 indexed citations

Jeong, Seung‐Hyun, et al.. (2023). Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(2). 145–157. 3 indexed citations

Jeong, Seung‐Hyun, Ji-Hun Jang, & Yong‐Bok Lee. (2023). Modeling population pharmacokinetics of morniflumate in healthy Korean men: extending pharmacometrics analysis to niflumic acid, its major active metabolite. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(2). 843–856. 3 indexed citations

Jeong, Seung‐Hyun, Ji-Hun Jang, & Yong‐Bok Lee. (2023). P-glycoprotein mechanical functional analysis using in silico molecular modeling: Pharmacokinetic variability according to ABCB1 c.2677G > T/A genetic polymorphisms. International Journal of Biological Macromolecules. 249. 126777–126777. 3 indexed citations

Jeong, Seung‐Hyun, Ji-Hun Jang, & Yong‐Bok Lee. (2023). Inter-individual exposure variability interpretation through reflection of biological age algorithm in physiologically based toxicokinetic model: Application to human risk assessment of di-isobutyl-phthalate. Environmental Pollution. 336. 122388–122388. 2 indexed citations

Kim, Se‐Mi, et al.. (2010). Bioequivalence of Procezil Tablet 250 mg to Cefzil® Tablet 250 mg (Cefprozil 250 mg). Korean Journal of Clinical Pharmacy. 20(3). 255–261. 1 indexed citations

Lee, Hye Won, Hye Young Ji, Dong Hwan Sohn, et al.. (2009). Liquid chromatography–tandem mass spectrometry method of loxoprofen in human plasma. Biomedical Chromatography. 23(7). 714–718. 7 indexed citations

Lee, Yong‐Bok, et al.. (2005). Design the Customer-oriented Marketing Decision Model using ANP (Analytic Network Process). Journal of the Korean society for quality management. 33(2). 32–39. 2 indexed citations

Lee, Hye Won, et al.. (2003). Determination of tiropramide in human plasma by liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 796(2). 395–400. 15 indexed citations

10.

Na, Kun, et al.. (2003). Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. European Journal of Pharmaceutical Sciences. 18(2). 165–173. 158 indexed citations

11.

Lee, Kyung-Dong, Yong‐Bok Lee, Min‐Suk Yang, & Pil‐Joo Kim. (2002). Effect of Soil Amendment Application on Yields and Effective Components of Chrysanthemum boreale M. 35(1). 27–37. 4 indexed citations

12.

Cho, Hea‐Young, et al.. (2001). Bioequivalence of Rebamide Tablet to Mucosta Tablet (Rebamipide 100 mg). Journal of Pharmaceutical Investigation. 31(4). 281–287. 1 indexed citations

13.

Cho, Hea‐Young, et al.. (2001). Bioequivalence of Carvelol Tablet to Dilatrend Tablet (Carvedilol 25 mg). Journal of Pharmaceutical Investigation. 31(4). 289–295. 1 indexed citations

14.

Kim, Soojin, et al.. (1999). Bioequivalence of Tigrin Capsule to Disgren Capsule (Triflusal 300 mg). Journal of Pharmaceutical Investigation. 29(4). 355–360. 1 indexed citations

15.

Lee, Hyub, et al.. (1998). Effects of Fly Ash,Gypsum,and Shell on the Chemical Properties of Soil and Growth of Chinese Cabbage in Plastic Film Housed Paddy. Korean Journal of Environmental Agriculture. 17(1). 65–69. 3 indexed citations

16.

Lee, Yong‐Bok, et al.. (1995). Mesenteric Lymphatic Delivery of Oral Anticancer Tegafur by Emulsion Formulations. Journal of Pharmaceutical Investigation. 25(1). 55–62. 1 indexed citations

17.

Lee, Yong‐Bok, et al.. (1992). The Effect of Phenobarbital Pretreatment on the Pharmacokinetics of Diltiazem in Rats. Journal of Pharmaceutical Investigation. 22(3). 219–227. 1 indexed citations

18.

Shin, Sang‐Chul, et al.. (1987). Enhancement of Dissolution Properties of Poorly Soluble Drugs (III) -Dissolution Enhancement of Furosemide from Ground Mixtures with Chitin or Chitosan-. Journal of Pharmaceutical Investigation. 17(4). 175–181. 1 indexed citations

19.

Shin, Sang‐Chul, et al.. (1986). Enhancement of Dissolution Properties of Ketoprofen from Ground Mixtures with Chitin or Chitosan. Journal of Pharmaceutical Investigation. 16(1). 36–41. 1 indexed citations

20.

Kim, Dong-Seon, et al.. (1966). Aqueous oxidation of sulfide ore (part 1) Aqueous Oxidation of Marmatite in Ammonia Solution. Journal of the Korean Chemical Society. 10(2). 54–58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact